{"entity":{"id":"nct07552181","kind":"trial","name":"Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer","aka":[],"tldr":"A phase 2 trial in triple-negative breast cancer, run by Yuan Yuan, not yet recruiting.","summary":"Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer is a phase 2, interventional study registered as NCT07552181 by Yuan Yuan, with a registry enrolment figure of 50 participants, started 2026-09 and due to reach its primary completion in 2035-09. Interventions recorded: Live biotherapeutic product: MO-03 1 capsule PO BID. Conditions listed: TNBC - Triple-Negative Breast Cancer; TNBC; Early Stage Triple-Negative Breast Carcinoma. Triple-negative eligibility wording from the registry: \"* Patients with high-risk early stage triple negative breast cancer\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07552181","url":"https://clinicaltrials.gov/study/NCT07552181"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07552181","phase":"2","setting":"Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer","sponsor":"Yuan Yuan","enrolled":50,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07552181/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}